Results 151 to 160 of about 53,085 (229)

Figure S2 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Chengxi Li, Yu‐Hsuan A. Chang, Minori Maki, Ikuko Omori, Naru Sato, Susumu Goyama, Toshio Kitamura, Yutaka Enomoto   +7 more
openalex   +1 more source

Bortezomib Suppresses Abnormal Proliferation, Migration, and Phenotypic Switching of Aortic Smooth Muscle Cells. [PDF]

Acta Cardiol Sin
Tseng YH, Wang LY, Kuan YH, Huang SE, Sulistyowati E, Tsai SP, Yeh JL, Hsu JH.   +7 more
europepmc   +1 more source

Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS [PDF]

Saad Z. Usmani, Thierry T.F. Facon, Vânia Hungria, Nizar Jacques Bahlis, Christopher Paul Venner, Marc Justin Braunstein, Luděk Pour, Josep Maria Martí, Supratik Basu, Yael Chava Cohen, Morio Matsumoto, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Wojciech Maciej Legiec, Meral Beksaç, Ângelo Maiolino, Hiroyuki Takamatsu, Aurore Perrot, Mehmet Turgut, Weiping Liu, Jianping Wang, Maria Krevvata, Jaclyn Stanziola, Matteo Loi, Emilie M.J. van Brummelen, Lorena Lopez-Masi, Melissa Rowe, Robin L. Carson, Sonja Zweegman   +29 more
openalex   +1 more source

Table S3 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Chengxi Li, Yu‐Hsuan A. Chang, Minori Maki, Ikuko Omori, Naru Sato, Susumu Goyama, Toshio Kitamura, Yutaka Enomoto   +7 more
openalex   +1 more source

miR-1248 enhances bortezomib-induced autophagy by targeting MEF2C/p38-MAPK signaling in multiple myeloma. [PDF]

Front Oncol
Wang W, Zhang RJ, Ma MS, Shi XM, Zhang Q, Li C, Zhang ZH, Hao CL.   +7 more
europepmc   +1 more source

Table S2 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Chengxi Li, Yu‐Hsuan A. Chang, Minori Maki, Ikuko Omori, Naru Sato, Susumu Goyama, Toshio Kitamura, Yutaka Enomoto   +7 more
openalex   +1 more source

Downregulation of mTORC1 Signaling is Associated with Increased Sensitivity to Protein Synthesis Perturbations in Multiple Myeloma. [PDF]

ACS Omega
Singha D, Choudhury D, Mondal M, Hossain J, Vedeshachaitanya B, Malakar P.   +5 more
europepmc   +1 more source

Figure S6 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Chengxi Li, Yu‐Hsuan A. Chang, Minori Maki, Ikuko Omori, Naru Sato, Susumu Goyama, Toshio Kitamura, Yutaka Enomoto   +7 more
openalex   +1 more source

Immunoglobulin A Subtype and Survival After Upfront Autologous Stem Cell Transplantation in Multiple Myeloma: A Real-World Cohort from the Bortezomib Era

Tuba Güllü Koca, Nizameddin Koca, Fazıl Çağrı Hunutlu, Ahmet Mert Yanık, Sinem Çubukçu, Rümeysa Yılmaz, Tuba Ersal, Vildan Gürsoy, İbrahim Ethem Pınar, Vildan Özkocaman, Fahir Özkalemkaş   +10 more
openalex   +1 more source

Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS. [PDF]

Leukemia
Zweegman S, Usmani SZ, Hungria V, Bahlis NJ, Venner CP, Braunstein M, Pour L, Marti JM, Basu S, Cohen YC, Matsumoto M, Suzuki K, Hulin C, Grosicki S, Legiec W, Maiolino A, Ngo M, Lopez-Masi L, Borgsten F, Rowe M, Carson RL, Facon T.   +21 more
europepmc   +1 more source